Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524400

ISHITADR

img img img img
No Data Available

ISHITA DRUGS & INDUSTRIES LTD. Share Price Update

As of the latest trading session, ISHITA DRUGS & INDUSTRIES LTD. share price is currently at ₹ 68.07, which is down by ₹ -1.93 from its previous closing. Today, the stock has fluctuated between ₹ 68.00 and ₹ 69.61. Over the past year, ISHITA DRUGS & INDUSTRIES LTD. has achieved a return of -17.64 %. In the last month alone, the return has been -10.02 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ISHITA DRUGS & INDUSTRIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    20.40

  • P/E Ratio (TTM)

    21.54

  • Beta

    -0.15

  • Book Value / share

    37.57

  • Return on equity

    8.40%

  • EPS (TTM)

    3.25

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.14

info icon alternate text

ISHITA DRUGS & INDUSTRIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 3.07
Operating Expense 2.91
Net Profit 0.14
Net Profit Margin (%) 4.56
Earnings Per Share (EPS) 0.48
EBITDA 0.25
Effective Tax Rate (%) 36.36
Particulars JUN 2025 (Values in Cr)
Revenue 5.40
Operating Expense 5.10
Net Profit 0.30
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 1.01
EBITDA 0.44
Effective Tax Rate (%) 23.07
Particulars MAR 2025 (Values in Cr)
Revenue 4.56
Operating Expense 4.34
Net Profit 0.29
Net Profit Margin (%) 6.35
Earnings Per Share (EPS) 0.96
EBITDA 0.44
Effective Tax Rate (%) 23.68
Particulars DEC 2024 (Values in Cr)
Revenue 4.13
Operating Expense 3.88
Net Profit 0.24
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 0.80
EBITDA 0.37
Effective Tax Rate (%) 25.00
Particulars SEP 2024 (Values in Cr)
Revenue 3.27
Operating Expense 3.06
Net Profit 0.19
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 0.65
EBITDA 0.29
Effective Tax Rate (%) 23.07
Particulars MAR 2025 (Values in Cr)
Revenue 15.00
Operating Expense 14.18
Net Profit 0.87
Net Profit Margin (%) 5.80
Earnings Per Share (EPS) 2.90
EBITDA 1.34
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 15.19
Operating Expense 14.48
Net Profit 0.75
Net Profit Margin (%) 4.93
Earnings Per Share (EPS) 2.50
EBITDA 1.19
Effective Tax Rate (%) 24.24
Particulars MAR 2023 (Values in Cr)
Revenue 12.07
Operating Expense 11.49
Net Profit 0.58
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 1.93
EBITDA 0.96
Effective Tax Rate (%) 25.64
Particulars MAR 2022 (Values in Cr)
Revenue 14.09
Operating Expense 13.15
Net Profit 0.81
Net Profit Margin (%) 5.74
Earnings Per Share (EPS) 2.69
EBITDA 1.19
Effective Tax Rate (%) 23.07
Particulars MAR 2021 (Values in Cr)
Revenue 13.95
Operating Expense 13.20
Net Profit 0.83
Net Profit Margin (%) 5.94
Earnings Per Share (EPS) 2.77
EBITDA 1.23
Effective Tax Rate (%) 20.95
Particulars MAR 2025 (Values in Cr)
Book Value / Share 36.08
ROE % 8.40
ROCE % 10.00
Total Debt to Total Equity 0.19
EBITDA Margin 8.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.18
ROE % 7.86
ROCE % 10.77
Total Debt to Total Equity 0.05
EBITDA Margin 7.83
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.68
ROE % 6.53
ROCE % 8.86
Total Debt to Total Equity 0.05
EBITDA Margin 7.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 28.75
ROE % 9.76
ROCE % 12.90
Total Debt to Total Equity 0.00
EBITDA Margin 8.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 26.05
ROE % 11.25
ROCE % 14.32
Total Debt to Total Equity 0.02
EBITDA Margin 8.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.83
Total Assets 16.29
Total Liabilities 16.29
Total Equity 10.78
Share Outstanding 2990300
Price to Book Ratio 2.18
Return on Assets (%) 5.32
Return on Capital (%) 5.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 10.80
Total Liabilities 10.80
Total Equity 9.92
Share Outstanding 2990300
Price to Book Ratio 1.98
Return on Assets (%) 6.92
Return on Capital (%) 7.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.42
Total Assets 11.40
Total Liabilities 11.40
Total Equity 9.17
Share Outstanding 2990300
Price to Book Ratio 1.61
Return on Assets (%) 5.06
Return on Capital (%) 5.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.68
Total Assets 11.25
Total Liabilities 11.25
Total Equity 8.59
Share Outstanding 2990300
Price to Book Ratio 1.44
Return on Assets (%) 7.15
Return on Capital (%) 9.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.53
Total Assets 9.26
Total Liabilities 9.26
Total Equity 7.79
Share Outstanding 2990300
Price to Book Ratio 1.15
Return on Assets (%) 8.95
Return on Capital (%) 10.65
Particulars MAR 2025 (Values in Cr)
Net Income 1.15
Cash from Operations -3.63
Cash from Investing -0.66
Cash from Financing 4.32
Net change in Cash 0.02
Free Cash Flow -3.45
Particulars MAR 2024 (Values in Cr)
Net Income 0.98
Cash from Operations 2.12
Cash from Investing 0.13
Cash from Financing -0.86
Net change in Cash 1.38
Free Cash Flow 2.14
Particulars MAR 2023 (Values in Cr)
Net Income 0.77
Cash from Operations -2.89
Cash from Investing 0.59
Cash from Financing 1.04
Net change in Cash -1.25
Free Cash Flow -2.76
Particulars MAR 2022 (Values in Cr)
Net Income 1.04
Cash from Operations 3.07
Cash from Investing -0.93
Cash from Financing 0.00
Net change in Cash 2.14
Free Cash Flow 3.09
Particulars MAR 2021 (Values in Cr)
Net Income 1.05
Cash from Operations -0.67
Cash from Investing 2.45
Cash from Financing -0.23
Net change in Cash 1.53
Free Cash Flow -0.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.01 12.26 1.29 191.66 24.01 / 53.83
BLISS GVS PHARMA LTD 161.95 15.63 1.51 1713.25 105.05 / 195.85
CIPLA LTD 1314.85 22.34 3.22 106209.80 1303.80 / 1672.20
FERMENTA BIOTECH LIMITED 311.30 8.18 2.34 916.19 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2311.50 41.08 22.93 39158.20 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.01 20.33 3.48 191.66 24.01 / 53.83
AMRUTAJAN HEALTH LTD 606.10 30.91 5.12 1752.27 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8305.85 89.82 25.98 20764.63 6501.60 / 10653.05
BLISS GVS PHARMA LTD 161.95 21.86 1.55 1713.25 105.05 / 195.85

ISHITA DRUGS & INDUSTRIES LTD. shareholding pattern

Holding

49.96%
50.03%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ISHITA DRUGS & INDUSTRIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
68.07 -2.75 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 70.90
  • 26 Days 73.90
  • 10 Days 72.30
  • 50 Days 74.30
  • 12 Days 72.80
  • 100 Days 74.90
  • 20 Days 73.70
  • 200 Days 75.90
70.00 PIVOT

First Support

70.00

First Resistance

70.00

Second Support

70.00

Second Resistance

70.00

Third Support

70.00

Third Resistance

70.00

RSI

42.55

ADX

34.67

MACD

-1.19

Williams % R

-82.61

Commodity Channel Index (CCI)

-113.19

Date

2026-01-23

Week

883.00

Same Day

105.00

Month

1727.00

1 Year

-0.16

3 Year

0.32

Over 1 Month

-10.02%

down

Over 1 Year

-17.64%

down

Over 3 Months

-5.40%

down

Over 3 Years

8.80%

down

Over 6 Months

-7.45%

down

Over 5 Years

17.31%

down

ISHITA DRUGS & INDUSTRIES LTD. Corporate Actions

Top Gainers

ISHITA DRUGS & INDUSTRIES LTD. Share Price

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. The company supplies its products to leading
pharmaceutical companies of India. The products are also being exported to various countries across the world. The plant has been designed and constructed to meet GMP norms.

The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).

Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.'95.

The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments.

During the year 2023-24, the GMP certification of the manufacturing facility of the Company was renewed by the regulatory authorities.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ishita Drugs & Industries Ltd?

Answer Field

Ishita Drugs & Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 68.07 as on Jan 27 2026 11:57 AM.

What is the Market Cap of Ishita Drugs & Industries Ltd Share?

Answer Field

The market cap of Ishita Drugs & Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 20.40 as on Jan 27 2026 11:57 AM.

What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?

Answer Field

The 52 Week High and Low of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 90.85 and ₹ 62.35.

What is 1 year return for Ishita Drugs & Industries Ltd?

Answer Field

The 1 year returns on the stock has been -17.64%.

What is the P/E Ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Jan 27 2026 11:57 AM the price-to-earnings (PE) ratio for Ishita Drugs & Industries Ltd share is 21.54.

What is the PB ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Jan 27 2026 11:57 AM, the price-to-book (PB) ratio for Ishita Drugs & Industries Ltd share is 37.57.

How to Buy Ishita Drugs & Industries Ltd Share?

Answer Field

You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ishita Drugs & Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Ishita Drugs & Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ishita Drugs & Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59